Merck

Merck to evaluate Variational AI’s Enki generative AI platform to design novel and selective small molecules Variational AI, developer of the…

Collaboration utilises BenevolentAI’s end-to-end AI platform capabilities to deliver novel drug candidates, initially for three targets in…

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to…

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’…

Perceiv AI announced that the company has been selected by Merck for the inaugural Merck Digital Sciences Studio (MDSS) cohort, along with eight other…

Merck, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, …

Collaboration leverages BigHat’s AI-enabled platform to expedite protein engineering to design and develop novel therapeutic candidates BigHat…

Merck, a leading science and technology company,  shared updates on the company’s healthcare research and development strategy, aimed at doubling…

Partnership will offer easy-to-use app and personalized cough frequency information to consumers including the estimated 12 million adults in the…

Merck is actively bringing technical and process expertise with various key African countries and customers to build local manufacturing capabilities…